154 related articles for article (PubMed ID: 27665209)
21. Risk and blood-borne virus testing among men who inject image and performance enhancing drugs, Sydney, Australia.
Rowe R; Berger I; Yaseen B; Copeland J
Drug Alcohol Rev; 2017 Sep; 36(5):658-666. PubMed ID: 28244160
[TBL] [Abstract][Full Text] [Related]
22. Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis C.
Alavi M; Spelman T; Matthews GV; Haber PS; Day C; van Beek I; Walsh N; Yeung B; Bruneau J; Petoumenos K; Dolan K; Kaldor JM; Dore GJ; Hellard M; Grebely J;
Int J Drug Policy; 2015 Oct; 26(10):976-83. PubMed ID: 26115881
[TBL] [Abstract][Full Text] [Related]
23. Development and validation of a novel scale for measuring interpersonal factors underlying injection drug using behaviours among injecting partnerships.
Morris MD; Neilands TB; Andrew E; Maher L; Page KA; Hahn JA
Int J Drug Policy; 2017 Oct; 48():54-62. PubMed ID: 28804051
[TBL] [Abstract][Full Text] [Related]
24. Venous access and care: harnessing pragmatics in harm reduction for people who inject drugs.
Harris M; Rhodes T
Addiction; 2012 Jun; 107(6):1090-6. PubMed ID: 22151433
[TBL] [Abstract][Full Text] [Related]
25. Trust and people who inject drugs: The perspectives of clients and staff of Needle Syringe Programs.
Treloar C; Rance J; Yates K; Mao L
Int J Drug Policy; 2016 Jan; 27():138-45. PubMed ID: 26394538
[TBL] [Abstract][Full Text] [Related]
26. More than just someone to inject drugs with: Injecting within primary injection partnerships.
Morris MD; Bates A; Andrew E; Hahn J; Page K; Maher L
Drug Alcohol Depend; 2015 Nov; 156():275-281. PubMed ID: 26460140
[TBL] [Abstract][Full Text] [Related]
27. "We get by with a little help from our friends": Small-scale informal and large-scale formal peer distribution networks of sterile injecting equipment in Australia.
Newland J; Newman C; Treloar C
Int J Drug Policy; 2016 Aug; 34():65-71. PubMed ID: 27449331
[TBL] [Abstract][Full Text] [Related]
28. High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14).
Wenz B; Nielsen S; Gassowski M; Santos-Hövener C; Cai W; Ross RS; Bock CT; Ratsch BA; Kücherer C; Bannert N; Bremer V; Hamouda O; Marcus U; Zimmermann R;
BMC Public Health; 2016 Sep; 16(1):927. PubMed ID: 27595567
[TBL] [Abstract][Full Text] [Related]
29. Promoting Safe Injection Practices, Substance Use Reduction, Hepatitis C Testing, and Overdose Prevention Among Syringe Service Program Clients Using a Computer-Tailored Intervention: Pilot Randomized Controlled Trial.
Hochstatter KR; Hull SJ; Sethi AK; Burns ME; Mundt MP; Westergaard RP
J Med Internet Res; 2020 Sep; 22(9):e19703. PubMed ID: 32990630
[TBL] [Abstract][Full Text] [Related]
30. Prevention knowledge, risk behaviours and seroprevalence among nonurban injectors of southwest Connecticut.
Grau LE; Zhan W; Heimer R
Drug Alcohol Rev; 2016 Sep; 35(5):628-36. PubMed ID: 27073014
[TBL] [Abstract][Full Text] [Related]
31. Barriers and facilitators of access to HIV, harm reduction and sexual and reproductive health services by women who inject drugs: role of community-based outreach and drop-in centers.
Ayon S; Ndimbii J; Jeneby F; Abdulrahman T; Mlewa O; Wang B; Ragi A; Mburu G
AIDS Care; 2018 Apr; 30(4):480-487. PubMed ID: 29067855
[TBL] [Abstract][Full Text] [Related]
32. 'There is no profile it is just everyone': the challenge of targeting hepatitis C education and prevention messages to the diversity of current and future injecting drug users.
Ellard J
Int J Drug Policy; 2007 May; 18(3):225-34. PubMed ID: 17689369
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis C among people who inject drugs in Tbilisi, Georgia: an urgent need for prevention and treatment.
Bouscaillou J; Champagnat J; Luhmann N; Avril E; Inaridze I; Miollany V; Labartkava K; Kirtadze I; Butsashvili M; Kamkamidze G; Pataut D
Int J Drug Policy; 2014 Sep; 25(5):871-8. PubMed ID: 24529802
[TBL] [Abstract][Full Text] [Related]
34. The intimate relationship as a site of social protection: Partnerships between people who inject drugs.
Rhodes T; Rance J; Fraser S; Treloar C
Soc Sci Med; 2017 May; 180():125-134. PubMed ID: 28343111
[TBL] [Abstract][Full Text] [Related]
35. HCV seroconversion in a cohort of people who use drugs followed in a mobile harm reduction unit in Madrid: Breaking barriers for HCV elimination.
Valencia La Rosa J; Ryan P; Alvaro-Meca A; Troya J; Cuevas G; Gutiérrez J; Moreno S
PLoS One; 2018; 13(10):e0204795. PubMed ID: 30281616
[TBL] [Abstract][Full Text] [Related]
36. Correlates of anti-hepatitis C positivity and use of harm reduction services among people who inject drugs in two cities in Croatia.
Handanagic S; Sevic S; Barbaric J; Dominkovic Z; Dakovic Rode O; Begovac J; Bozicevic I
Drug Alcohol Depend; 2017 Feb; 171():132-139. PubMed ID: 28088084
[TBL] [Abstract][Full Text] [Related]
37. Gender differences in hepatitis C antibody prevalence and risk behaviours amongst people who inject drugs in Australia 1998-2008.
Iversen J; Wand H; Gonnermann A; Maher L;
Int J Drug Policy; 2010 Nov; 21(6):471-6. PubMed ID: 20472417
[TBL] [Abstract][Full Text] [Related]
38. Harm reduction via online platforms for people who use drugs in Russia: a qualitative analysis of web outreach work.
Davitadze A; Meylakhs P; Lakhov A; King EJ
Harm Reduct J; 2020 Dec; 17(1):98. PubMed ID: 33298081
[TBL] [Abstract][Full Text] [Related]
39. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia.
Maher L; Chant K; Jalaludin B; Sargent P
J Gastroenterol Hepatol; 2004 Oct; 19(10):1114-20. PubMed ID: 15377287
[TBL] [Abstract][Full Text] [Related]
40. Increased Uptake of HCV Testing through a Community-Based Educational Intervention in Difficult-to-Reach People Who Inject Drugs: Results from the ANRS-AERLI Study.
Roux P; Rojas Castro D; Ndiaye K; Debrus M; Protopopescu C; Le Gall JM; Haas A; Mora M; Spire B; Suzan-Monti M; Carrieri P
PLoS One; 2016; 11(6):e0157062. PubMed ID: 27294271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
